bf/NASDAQ:RGLS_icon.jpeg

COM:REGULUSRX

Regulus Therapeutics

  • Stock

USD

Last Close

1.40

22/11 21:00

Market Cap

115.22M

Beta: -

Volume Today

288.02K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-18.67M
-
-56.68M
203.62%
-55.75M
1.64%
-81.84M
46.80%
-71.91M
12.14%
-48.71M
32.26%
-18.59M
61.83%
-15.73M
15.39%
-27.81M
76.78%
-28.32M
1.85%
-30.04M
6.05%
depreciation and amortization
1.36M
-
1.49M
9.56%
1.59M
6.78%
2.28M
43.05%
2.52M
10.90%
2.26M
10.38%
931K
58.84%
467K
49.84%
459K
1.71%
122K
73.42%
70K
42.62%
deferred income tax
-2.30M
-
5.10M
321.42%
-15.27M
399.59%
666K
104.36%
349K
47.60%
148K
57.59%
-662K
-
stock based compensation
3.42M
-
7.04M
105.70%
15.37M
118.33%
12.87M
16.24%
7.64M
40.63%
5.44M
28.80%
2.29M
57.95%
2.61M
14.25%
2.92M
11.82%
2.18M
25.52%
2.80M
28.66%
change in working capital
-17.03M
-
-5.09M
70.10%
-14.45M
183.80%
8.10M
156.03%
2.02M
75.09%
-3.17M
257.21%
-6.58M
107.51%
-41K
99.38%
914K
2,329.27%
550K
39.82%
29K
94.73%
accounts receivables
6.64M
-
347K
-
-1.11M
421.33%
638K
157.22%
503K
21.16%
inventory
-616K
-
-606K
-
270
100.04%
610
125.93%
304
50.16%
accounts payables
860K
-
940K
9.30%
529K
43.72%
3.12M
490.36%
-65K
102.08%
-4.03M
6,098.46%
-393K
90.25%
-786K
100%
-250K
68.19%
-110K
56.00%
29K
126.36%
other working capital
-17.89M
-
-6.03M
66.28%
-14.98M
148.34%
-1.05M
92.98%
2.08M
298.10%
1.12M
46.35%
-5.07M
554.10%
106.39K
102.10%
660.70K
521.01%
660K
0.11%
-29K
104.39%
other non cash items
4.89M
-
8.64M
76.75%
18.65M
115.97%
1.04M
94.41%
600K
42.47%
756K
26%
2.13M
182.01%
154K
92.78%
46K
70.13%
-52K
213.04%
398K
865.38%
net cash provided by operating activities
-28.33M
-
-39.51M
39.46%
-49.86M
26.19%
-56.88M
14.09%
-58.77M
3.32%
-43.27M
26.37%
-19.82M
54.20%
-12.54M
36.75%
-24.13M
92.47%
-25.53M
5.79%
-26.77M
4.87%
investments in property plant and equipment
-835K
-
-1.21M
45.03%
-1.43M
18.08%
-966K
32.45%
-319K
66.98%
-22K
93.10%
-244K
1,009.09%
-11K
95.49%
-251K
2,181.82%
-361K
43.82%
-613K
69.81%
acquisitions net
35K
-
65K
85.71%
67K
3.08%
53K
20.90%
16K
69.81%
318K
-
14.76K
-
purchases of investments
-72.00M
-
-113.42M
57.51%
-78.40M
30.87%
-65.11M
16.95%
-55.69M
14.47%
-32.76M
-
-4.90M
85.05%
sales maturities of investments
31.95M
-
85.42M
167.35%
101.31M
18.60%
101.39M
0.08%
69.94M
31.02%
46.54M
33.46%
18M
-
20M
11.11%
other investing activites
-35K
-
-65K
85.71%
-67K
3.08%
-53K
20.90%
-16K
69.81%
-14.76K
-
3K
120.33%
net cash used for investing activites
-40.89M
-
-29.21M
28.57%
21.48M
173.53%
35.31M
64.43%
13.94M
60.53%
46.52M
233.80%
74K
99.84%
-11K
114.86%
-251K
2,181.82%
-15.12M
5,923.90%
14.49M
195.84%
debt repayment
-167K
-
-3.34M
-
-2.24M
32.97%
-10.28M
358.79%
-80K
99.22%
common stock issued
46.57M
-
88.38M
89.76%
7.17M
91.88%
641K
91.06%
43.41M
6,672.39%
219K
99.50%
42.17M
19,155.71%
19.12M
54.65%
53.79M
181.29%
4.49M
91.65%
1.12M
75.13%
common stock repurchased
dividends paid
other financing activites
-100K
-
-142K
42%
-155K
9.15%
20.08M
13,053.55%
4K
99.98%
293K
7,225%
3K
98.98%
667K
22,133.33%
26K
96.10%
10.70M
-
net cash used provided by financing activities
46.47M
-
88.24M
89.86%
7.02M
92.05%
20.55M
192.89%
43.41M
111.24%
-2.83M
106.52%
39.93M
1,511.06%
9.51M
76.18%
53.74M
464.88%
4.49M
91.64%
11.82M
163.10%
effect of forex changes on cash
net change in cash
-22.75M
-
19.52M
185.82%
-21.37M
209.46%
-1.02M
95.23%
-1.42M
39.55%
416K
129.25%
20.19M
4,752.40%
-3.03M
115.03%
29.36M
1,067.63%
-36.16M
223.15%
-461K
98.72%
cash at beginning of period
40.55M
-
17.81M
56.09%
37.33M
109.62%
15.96M
57.24%
14.94M
6.38%
13.52M
9.52%
13.94M
3.08%
34.12M
144.86%
31.09M
8.89%
60.45M
94.44%
24.29M
59.81%
cash at end of period
17.81M
-
37.33M
109.62%
15.96M
57.24%
14.94M
6.38%
13.52M
9.52%
13.94M
3.08%
34.12M
144.86%
31.09M
8.89%
60.45M
94.44%
24.29M
59.81%
23.83M
1.90%
operating cash flow
-28.33M
-
-39.51M
39.46%
-49.86M
26.19%
-56.88M
14.09%
-58.77M
3.32%
-43.27M
26.37%
-19.82M
54.20%
-12.54M
36.75%
-24.13M
92.47%
-25.53M
5.79%
-26.77M
4.87%
capital expenditure
-835K
-
-1.21M
45.03%
-1.43M
18.08%
-966K
32.45%
-319K
66.98%
-22K
93.10%
-244K
1,009.09%
-11K
95.49%
-251K
2,181.82%
-361K
43.82%
-613K
69.81%
free cash flow
-29.16M
-
-40.72M
39.62%
-51.29M
25.95%
-57.85M
12.79%
-59.09M
2.15%
-43.30M
26.73%
-20.07M
53.66%
-12.55M
37.47%
-24.38M
94.30%
-25.89M
6.19%
-27.38M
5.77%

All numbers in USD (except ratios and percentages)